286 related articles for article (PubMed ID: 25963273)
1. Ca(2+) handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington's disease.
Pellman JJ; Hamilton J; Brustovetsky T; Brustovetsky N
J Neurochem; 2015 Aug; 134(4):652-67. PubMed ID: 25963273
[TBL] [Abstract][Full Text] [Related]
2. Oxidative metabolism and Ca
Hamilton J; Brustovetsky T; Brustovetsky N
Neurochem Int; 2017 Oct; 109():24-33. PubMed ID: 28062223
[TBL] [Abstract][Full Text] [Related]
3. Oxidative metabolism in YAC128 mouse model of Huntington's disease.
Hamilton J; Pellman JJ; Brustovetsky T; Harris RA; Brustovetsky N
Hum Mol Genet; 2015 Sep; 24(17):4862-78. PubMed ID: 26041817
[TBL] [Abstract][Full Text] [Related]
4. Oxidative metabolism and Ca2+ handling in isolated brain mitochondria and striatal neurons from R6/2 mice, a model of Huntington's disease.
Hamilton J; Pellman JJ; Brustovetsky T; Harris RA; Brustovetsky N
Hum Mol Genet; 2016 Jul; 25(13):2762-2775. PubMed ID: 27131346
[TBL] [Abstract][Full Text] [Related]
5. Mutant huntingtin fails to directly impair brain mitochondria.
Hamilton J; Brustovetsky T; Brustovetsky N
J Neurochem; 2019 Dec; 151(6):716-731. PubMed ID: 31418857
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Store-Operated Calcium Entry Leads to Striatal Synaptic Loss in a Huntington's Disease Mouse Model.
Wu J; Ryskamp DA; Liang X; Egorova P; Zakharova O; Hung G; Bezprozvanny I
J Neurosci; 2016 Jan; 36(1):125-41. PubMed ID: 26740655
[TBL] [Abstract][Full Text] [Related]
7. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease.
Fernandes HB; Baimbridge KG; Church J; Hayden MR; Raymond LA
J Neurosci; 2007 Dec; 27(50):13614-23. PubMed ID: 18077673
[TBL] [Abstract][Full Text] [Related]
9. Characterization of subventricular zone-derived progenitor cells from mild and late symptomatic YAC128 mouse model of Huntington's disease.
Silva AC; Ferreira IL; Hayden MR; Ferreiro E; Rego AC
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):34-44. PubMed ID: 28939435
[TBL] [Abstract][Full Text] [Related]
10. Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model.
Gladding CM; Fan J; Zhang LY; Wang L; Xu J; Li EH; Lombroso PJ; Raymond LA
J Neurochem; 2014 Jul; 130(1):145-59. PubMed ID: 24588402
[TBL] [Abstract][Full Text] [Related]
11. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease.
Li E; Park HR; Hong CP; Kim Y; Choi J; Lee S; Park HJ; Lee B; Kim TA; Kim SJ; Kim HS; Song J
Cell Prolif; 2020 Oct; 53(10):e12893. PubMed ID: 32865873
[TBL] [Abstract][Full Text] [Related]
12. Mutant huntingtin does not cross the mitochondrial outer membrane.
Hamilton J; Brustovetsky T; Khanna R; Brustovetsky N
Hum Mol Genet; 2020 Oct; 29(17):2962-2975. PubMed ID: 32821928
[TBL] [Abstract][Full Text] [Related]
13. Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease.
Van Raamsdonk JM; Pearson J; Murphy Z; Hayden MR; Leavitt BR
BMC Neurosci; 2006 Dec; 7():80. PubMed ID: 17147801
[TBL] [Abstract][Full Text] [Related]
14. C57BL/6 Background Attenuates mHTT Toxicity in the Striatum of YAC128 Mice.
Back MK; Kurzawa J; Ruggieri S; von Engelhardt J
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884469
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice.
Oliveira JM; Jekabsons MB; Chen S; Lin A; Rego AC; Gonçalves J; Ellerby LM; Nicholls DG
J Neurochem; 2007 Apr; 101(1):241-9. PubMed ID: 17394466
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
17. Altered mitochondrial Ca
Yoo H; Park H
Biochem Biophys Res Commun; 2024 Jul; 716():150010. PubMed ID: 38704892
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial and redox modifications in early stages of Huntington's disease.
Lopes C; Ferreira IL; Maranga C; Beatriz M; Mota SI; Sereno J; Castelhano J; Abrunhosa A; Oliveira F; De Rosa M; Hayden M; Laço MN; Januário C; Castelo Branco M; Rego AC
Redox Biol; 2022 Oct; 56():102424. PubMed ID: 35988447
[TBL] [Abstract][Full Text] [Related]
19. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.
Oliveira JM
J Neurochem; 2010 Jul; 114(1):1-12. PubMed ID: 20403078
[TBL] [Abstract][Full Text] [Related]
20. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
